1st Call of the European One Health Partnership – Antimicrobial Resistance

The European Partnership One Health – Antimicrobial Resistance (OH-AMR), which includes the Foundation for Science and Technology (FCT), will launch its first joint Call for funding research and innovation projects on November 18, under the theme “New treatments to tackle AMR.” This Call the participation of funding institutions from 28 countries and aims to support projects that contribute to developing new approaches to combat antimicrobial resistance.

Research and innovation proposals submitted to Call focus on one of the following topics:

1. Identify and develop new combination treatments, using existing or innovative antimicrobials, or combining antimicrobials with complementary treatments, with the aim of prolonging the effectiveness of drugs and combating resistance.
2. Develop tools and methods to improve adherence to treatment protocols.
3. Assess the impact of antimicrobial use in veterinary medicine and agriculture on the risk of antimicrobial resistance (AMR) transmission to humans and the environment, with a view to informing policies that restrict the use of certain antimicrobials in human medicine.

Applications may be submitted from November 18, 2025, to February 2, 2026 , until 12:00 p.m. (Mainland Portugal time). To support potential applicants, an informationalwebinar will be held on November 26, at 1:00 p.m. (Mainland Portugal time).

More information about the Call available on the partnership page, and additional information will be published after the launch.

The OH-AMR Partnership is co-funded by the Horizon Europe program and promotes an integrated One Health approach, involving human, animal, plant, and environmental health, with the aim of preventing and controlling antimicrobial resistance (AMR). It brings together 53 entities from 30 countries, including Portugal, represented by FCT and the Agency for Clinical Research and Biomedical Innovation (AICIB).